SEVERE OBESITY
Clinical trials for SEVERE OBESITY explained in plain language.
Never miss a new study
Get alerted when new SEVERE OBESITY trials appear
Sign up with your email to follow new studies for SEVERE OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a diabetes drug boost weight loss after bypass surgery?
Disease control ENROLLING_BY_INVITATIONThis study tests whether tirzepatide, a GLP-1 drug, can help people with severe obesity lose more weight a year after gastric bypass surgery. About 30 adults will either take the drug or continue standard care. Researchers will track weight, body fat, and side effects to see if t…
Matched conditions: SEVERE OBESITY
Phase: PHASE2, PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 26, 2026 07:12 UTC
-
Can a diabetes drug help kids with severe obesity lose weight and protect their hearts?
Disease control OngoingThis study tests whether liraglutide, a drug used for diabetes and weight loss, can help children aged 6 to 12 with severe obesity lose weight and improve heart function. About 30 children will receive either the drug plus lifestyle advice or lifestyle advice alone for 6 months. …
Matched conditions: SEVERE OBESITY
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
Battle of the bariatric surgeries: which one wins for severe obesity?
Disease control OngoingThis study compares two weight-loss surgeries—sleeve gastrectomy with transit bipartition and Roux-en-Y gastric bypass—in 320 adults with severe obesity. The goal is to see which surgery leads to more weight loss and fewer complications over two years. Participants must have a BM…
Matched conditions: SEVERE OBESITY
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 26, 2026 07:01 UTC